April W. Armstrong, MD, MPH - A New Era in Psoriasis Care With Oral IL-23 Inhibitors

April W. Armstrong, MD, MPH - A New Era in Psoriasis Care With Oral IL-23 Inhibitors

May 7, 2026 · 34 min

About this episode

This episode discusses advancements in psoriasis care with a focus on oral IL-23 inhibitors.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WNB865. CME/AAPA credit will be available until April 21, 2027. A New Era in Psoriasis Care With Oral IL-23 Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an educational grant from Johnson & Johnson. Disclosure information is available at the beginning of the video presentation.

Sponsors

Johnson & Johnson

More episodes of PeerView Immunology & Transplantation CME/CNE/CPE Audio Podcast

Explore listener stats, chart rankings, contacts and more on the PeerView Immunology & Transplantation CME/CNE/CPE Audio Podcast podcast page.